ID: ALA3612240

Max Phase: Preclinical

Molecular Formula: C15H20ClNO2

Molecular Weight: 245.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.O=C(Oc1ccccc1)[C@@H]1[C@H]2CCC[C@@H]1NCC2

Standard InChI:  InChI=1S/C15H19NO2.ClH/c17-15(18-12-6-2-1-3-7-12)14-11-5-4-8-13(14)16-10-9-11;/h1-3,6-7,11,13-14,16H,4-5,8-10H2;1H/t11?,13?,14-;/m1./s1

Standard InChI Key:  ARRURUNIWNVUDW-CCMUJUARSA-N

Associated Targets(non-human)

Mu opioid receptor-like OR2 18 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 245.32Molecular Weight (Monoisotopic): 245.1416AlogP: 2.37#Rotatable Bonds: 2
Polar Surface Area: 38.33Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.46CX LogP: 2.60CX LogD: 0.57
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.64Np Likeness Score: 0.24

References

1. Nieto CT, Gonzalez-Nunez V, Rodríguez RE, Diez D, Garrido NM..  (2015)  Design, synthesis, pharmacological evaluation and molecular dynamics of β-amino acids morphan-derivatives as novel ligands for opioid receptors.,  101  [PMID:26134550] [10.1016/j.ejmech.2015.06.025]

Source